Alps Advisors Inc Keros Therapeutics, Inc. Transaction History

Alps Advisors Inc

$17.8 Billion
Q3 2025

A detailed history of Alps Advisors Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 19,673 shares of KROS stock, worth $339,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,673

Previous 21,949 10.37%

Holding current value

$339,555

Previous $293,000 6.14%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$13.34 - $16.05 $30,361 - $36,529	-2,276 Reduced 10.37%	19,673 $311,000
Q2 2025 Aug 11, 2025	SELL	$9.55 - $15.11 $74,365 - $117,661	-7,787 Reduced 26.19%	21,949 $293,000
Q1 2025 Apr 30, 2025	SELL	$10.15 - $16.1 $30,653 - $48,622	-3,020 Reduced 9.22%	29,736 $303,000
Q4 2024 Feb 13, 2025	BUY	$15.64 - $70.0 $75,869 - $339,570	4,851 Added 17.38%	32,756 $518,000
Q3 2024 Nov 12, 2024	SELL	$41.68 - $58.07 $9,961 - $13,878	-239 Reduced 0.85%	27,905 $1.62 Million

Q2 2024 Aug 13, 2024	BUY	$44.58 - $66.89 $123,308 - $185,017	2,766 Added 10.9%	28,144 $1.29 Million
Q1 2024 May 14, 2024	BUY	$41.26 - $70.48 $237,905 - $406,387	5,766 Added 29.4%	25,378 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$27.12 - $41.05 $61,860 - $93,635	-2,281 Reduced 10.42%	19,612 $779,000
Q3 2023 Nov 14, 2023	BUY	$31.57 - $43.02 $4,703 - $6,409	149 Added 0.69%	21,893 $697,000
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $109,507 - $149,918	2,939 Added 15.63%	21,744 $873,000
Q1 2023 May 10, 2023	BUY	$41.44 - $59.32 $4,889 - $6,999	118 Added 0.63%	18,805 $802,000
Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $184,034 - $241,507	4,665 Added 33.27%	18,687 $897,000
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $6,672 - $9,628	-240 Reduced 1.68%	14,022 $528,000
Q2 2022 Aug 11, 2022	SELL	$26.03 - $67.04 $270,946 - $697,819	-10,409 Reduced 42.19%	14,262 $394,000
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $101,088 - $142,464	-2,400 Reduced 8.87%	24,671 $1.34 Million
Q4 2021 Feb 09, 2022	SELL	$36.95 - $62.89 $56,459 - $96,095	-1,528 Reduced 5.34%	27,071 $1.58 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $61,115 - $91,266	-2,088 Reduced 6.8%	28,599 $1.13 Million
Q2 2021 Aug 11, 2021	BUY	$42.4 - $70.11 $1.3 Million - $2.15 Million	30,687 New	30,687 $1.3 Million

Others Institutions Holding KROS

# of Institutions

169

Shares Held

35.4M

Call Options Held

574K

Put Options Held

325K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Keros Therapeutics, Inc. Transaction History